Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Better Prognosis for Breast Cancer in Germany

04.05.2012
Excellent treatment results testify to high quality of care at Heidelberg University Hospital’s Breast Center / First publication of prospectively collected data in Germany

How successful is the interdisciplinary treatment of breast cancer? Since 2003, the Breast Center at Heidelberg University Hospital has systematically tracked the course of breast cancer in more than 3,000 patients and, as the first center in Germany, has published these significant prospective results: Eighty-six percent of the patients survived the first five years after onset of treatment, with 80 % of them remaining disease-free during this period. The evaluation was published online in February 2012 in the journal The Breast.

“The prognosis for breast cancer has further improved thanks to new treatment options and consistent interdisciplinary treatment,” said Prof. Christof Sohn, Managing Director of the Heidelberg University Women’s Hospital and Director of the Breast Center. This is proven by the results of treatment in Heidelberg. An evaluation of the German cancer registry for the period from 2000 to 2004 conducted by Robert Koch Institute in 2010 yielded a probability of 79.6 % for disease-free survival in the first five years after treatment. A current study by the German Cancer Research Center (DKFZ) that analyzed the data of 11 German cancer registries from the period from 2002 to 2006 yielded a probability of approx. 84 %. In the United States, according to the National Cancer Institute, this probability was 89 % for the period from 1999 to 2006.

Eighty-six percent of the patients were still alive five years after treatment

The interdisciplinary team in Heidelberg headed by Prof. Andreas Schneeweiss, head of the section of Gynecological Oncology at the National Center for Tumor Diseases and the Heidelberg University Hospital Women’s Hospital and by Dr. Jörg Heil, head physician and coordinator of the Heidelberg University Hospital Breast Center, evaluated the data of all 3,338 patients newly diagnosed with malignant breast cancer treated at Heidelberg University Hospital’s Breast Center from 2003 to 2010. Five years after initial treatment, 80 % were disease-free, i.e., the cancer had not recurred. In 15 % of the patients, a tumor had recurred in the breast and in 19 %, metastases had occurred, with some patients experiencing both. Eighty-six percent of the patients survived the first five years after initial diagnosis. Taking the deaths into account that were not attributed to the breast cancer, the evaluation showed that only 10 % of the patients died from breast cancer during the first five years after diagnosis.

Interdisciplinary tumor board provides recommendations for treatment

“Our results serve as a basis for further improving preventative care and treatment of breast cancer patients,” said Prof. Schneeweiss. “In this area, with the structures created at the National Center for Tumor Diseases in Heidelberg, we are setting the standards for other centers in Germany.” Since 2003, Prof. Schneeweiss has managed the meticulous documentation of all breast cancer cases, which now constitutes the data base for this and other such analyses and will continue to do so in the future. Prof. Schneeweiss is also the head of the interdisciplinary tumor board and is therefore responsible for drawing up the individual interdisciplinary treatment recommendations.
In 2003, the Breast Center at Heidelberg University Women’s Hospital was one of the first centers in Germany to be certified by the German Cancer Society and the German Society for Senology. Today, there are more than 200 certified breast centers in Germany. In 2006, the Breast Center was accredited by the European Society of Breast Cancer Specialists (EUSOMA). For patients, this means that an experienced team of physicians and modern treatment options ensure high-quality diagnostics and treatment through multidisciplinary cooperation. In 2011, Heidelberg University Hospital’s Breast Center treated over 600 newly diagnosed patients, making it one of Germany’s largest breast centers.

Literature:
J. Heil, A. Gondos, G. Rauch, F. Marmé, J. Rom, M. Golatta, H. Junkermann, P. Sinn, S. Aulmann, J. Debus, H. Hof, F. Schütz, H. Brenner, C. Sohn, A. Schneeweiss. Outcome analysis patients with primary breast cancer initially treated at a certified academic breast unit. The Breast (2012), doi:10.1016/j.breast.2012.01.009

J. Haberland, J. Bertz, U. Wolf, T. Ziese, B.M. Kurth: German cancer statistics 2004. BMC Cancer, 10 (2010), p. 52

E. Hiripi, A. Gondos, K. Emrich, B. Holleczek, A. Katalinic, S. Luttmann et al.: Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol, 23 (2012), pp. 472–479

S. Altekruse, C. Kosary, M. Krapcho: SEER cancer statistics review, 1975–2007. National Cancer Institute (2010) http://seer.cancer.gov/csr/1975_2007/

Internet:
http://www.klinikum.uni-heidelberg.de/Brustzentrum.103928.0.html

Contact:
Dr. Jörg Heil
Head physician and coordinator of the
Heidelberg University Hospital Breast Center
phone +49 - 6221 56 77 22
e-mail: joerg.heil@med.uni-heidelberg.de

About Heidelberg University Hospital:
Heidelberg University Hospital and the Medical Faculty of Heidelberg University
Patient Care, Research and Teaching of International Standard
Heidelberg University Hospital is among the largest and most renowned medical centers in Germany. The Medical Faculty of Heidelberg University ranges among the internationally relevant biomedical research institutes in Europe. The common goal is to develop new therapies and to apply them rapidly for the benefit of the patient. The Hospital and the Faculty have approximately 11,000 employees and are active in training and qualification. In more than 50 departments, clinics and special departments with about 2,000 hospital beds, approximately 600,000 patients receive inpatient and outpatient treatment each year. There are currently about 3,600 aspiring doctors studying medicine in Heidelberg; the Heidelberg Curriculum Medicinale (HeiCuMed) is at the top of medical teaching and training in Germany.
Requests by journalists:
Dr. Annette Tuffs
Head of Public Relations and Press Department
University Hospital of Heidelberg and
Medical Faculty of Heidelberg
Im Neuenheimer Feld 672
D-69120 Heidelberg
Germany
phone: +49 6221 / 56 45 36
fax: +49 6221 / 56 45 44
e-mail: annette.tuffs(at)med.uni-heidelberg.de

Selected english press releases online:
http://www.klinikum.uni-heidelberg.de/presse

Dr. Annette Tuffs | idw
Further information:
http://www.klinikum.uni-heidelberg.de

More articles from Health and Medicine:

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

Scientist invents way to trigger artificial photosynthesis to clean air

26.04.2017 | Materials Sciences

Ammonium nitrogen input increases the synthesis of anticarcinogenic compounds in broccoli

26.04.2017 | Agricultural and Forestry Science

SwRI-led team discovers lull in Mars' giant impact history

26.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>